MicroRNA-29b-3p reduces intestinal ischaemia/reperfusion injury via targeting of TNF receptor-associated factor 3.

Yan DaiZhang MaoXu HanYouwei XuLina XuLianhong YinYan QiJinyong Peng

Published in: British journal of pharmacology (2019)

The miR-29b-3p played a critical role in II/R injury, via targeting TRAF3, which should be considered as a significant drug target to treat the disease.

Keyphrases

cancer therapy
rheumatoid arthritis
acute myocardial infarction
heart failure
drug delivery
coronary artery disease
atrial fibrillation